基于机制的过氧化3抑制剂利用共价核弹头进行癌症治疗
Kimberly J Nelson1,2,3, Terrence L Smalley1,2, Terri Messier4
1Department of Biochemistry, Center for Structural Biology, Wake Forest University School of Medicine, Medical Center Blvd., Winston-Salem, NC 27157, USA.
Science advances
|October 31, 2025
概括
研究人员确定了选择性抑制三氧化素3,提供潜在的亲氧化剂癌症治疗的Thiostrepton (TS) 的最小片段. 这种含有脱水氨酸 (DHA) 的碎片对癌症治疗有前途.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 共价抑制剂在药物开发中至关重要,它们向氨基酸侧链.
- 提奥斯特普顿 (TS) 通过交叉连接活性部位的囊蛋白,增加反应性氧物种 (ROS) 和诱导癌细胞死亡来抑制过氧素3 (PRX3).
- 在临床前癌症模型和正在进行的恶性间皮瘤临床试验中,PRX3无活化显示出治疗前景.
研究的目的:
- 为了确定TS保留抗癌活性的最小片段.
- 为了将此片段描述为选择性氧素抑制剂.
- 评估脱水氨酸 (DHA) 作为癌症治疗中的共价核弹头的潜力.
主要方法:
- 生物化学测定 生物化学测定
- 运动学研究 运动学研究
- 细胞检测试验 细胞检测试验
- 结构研究 结构研究
主要成果:
- 确定了一个最小的TS片段与协同的脱水氨酸 (DHA) 部分.
- 这个片段通过基于机制的抑制来选择性地抑制过氧化素3 (PRX3).
- 片段保持抗癌活性,同时失去完整的TS的非目标相互作用.
- 证实DHA部分是一种强大的共价核弹头.
结论:
- 最小的TS片段是一种具有抗癌活性的强效和选择性PRX3抑制剂.
- 这一发现支持癌症治疗的亲氧化剂策略.
- 脱水氨酸 (DHA) 应该被视为一种有价值的补充,用于药物开发的共价弹头武器库.
相关概念视频
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Peroxisomes
19.9K
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
19.9K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Redox Reactions
58.2K
Oxidation-reduction or redox reactions involve the transfer of electrons from one molecule or atom to another. When an atom gains an electron, another atom must lose an electron, meaning oxidation and reduction must occur together. Since the redox occurs in pairs, the atom that gets oxidized is also called the reducing agent or reductant, and the atom that is reduced is also called the oxidizing agent or oxidant. A straightforward way to remember the definitions of oxidation and reduction is...
58.2K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


